To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 13, 2025

Primary Completion Date

May 20, 2025

Study Completion Date

May 20, 2025

Conditions

Healty Volunteers

Interventions

DRUG

KP-001

KP-001 100 mg dry syrup

DRUG

Rosuvastatin calcium10mg

A oral dose of 10 mg tablet

DRUG

Caffeine citrate

100 mg oral solution

DRUG

Fluvoxamine

50 mg tablet

Trial Locations (1)

Parexel International Early Phase Clinical Unit, Glendale